News Announcement

Strides Pharma Science: Disclosure Under Regulation 30 Of SEBI Listing Regulations

This has reference to the Press Release issued by the Company today titled - Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz.In this regard please find enclosed herewith disclosure under Regulation 30 of SEBI Listing Regulations.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.